Difference in Impact of CYP2C19 Polymorphism on Platelet Reactivity and Clinical Outcomes Between Acute Coronary Syndrome (ACS) and Stable Angina

被引：0
|
作者：
Hokimoto, Seiji [1 ]
Akasaka, Tomonori [1 ]
Kaikita, Koichi [1 ]
Nakagawa, Kazuko [2 ]
Ogawa, Hisao [1 ]
机构：
[1] Kumamoto Univ, Dept Cardiovasc Med, Kumamoto, Japan
[2] Kumamoto Univ, Div Pharmacol & Therapeut, Kumamoto, Japan
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Acute coronary syndromes; Pharmacogenetics; Percutaneous coronary intervention; Genetics;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16546
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel
    Qiu, Li-Na
    Sun, Yan
    Wang, Lin
    Han, Rui-Fa
    Xia, Xiao-Shuang
    Liu, Jie
    Li, Xin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 747 : 29 - 35
  • [32] Influence of CYP2C19 polymorphisms in on-treatment platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome
    Tello-Montoliu, A.
    Jover, E.
    Marin, F.
    Bernal, A.
    Lozano, M. L.
    Sanchez-Vega, B.
    Pastor-Perez, F.
    Hurtado, J. A.
    Valdes, M.
    Rivera, J.
    EUROPEAN HEART JOURNAL, 2011, 32 : 264 - 264
  • [33] Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study
    Kuo, Feng-Yu
    Lee, Cheng-Han
    Lan, Wei-Ren
    Su, Cheng-Huang
    Lee, Wen-Lieng
    Wang, Yi-Chih
    Lin, Wei-Shiang
    Chu, Pao-Hsien
    Lu, Tse-Min
    Lo, Ping-Han
    Tsukiyama, Shuji
    Yang, Wei-Chen
    Cheng, Li-Chung
    Huang, Chien-Lung
    Yin, Wei-Hsian
    Liu, Ping-Yen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (09) : 1786 - 1797
  • [34] The clinical impact of CYP2C19 *2 and *3 polymorphism on Clopidogrel and cost analysis
    Al Meman A
    Khalaf H
    Rasool Seemab
    BMC Genomics, 15 (Suppl 2)
  • [35] Gender Differences in Impact of CYP2C19 Polymorphism on Development of Coronary Artery Disease
    Hokimoto, Seiji
    Tabata, Noriaki
    Akasaka, Tomonori
    Arima, Yuichiro
    Kaikita, Koichi
    Morita, Kazunori
    Kumagae, Naoki
    Oniki, Kentaro
    Nakagawa, Kazuko
    Ogawa, Hisao
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 65 (02) : 148 - 152
  • [36] CYP2C19 Poor Metabolizer Is Associated With Clinical Outcome of Clopidogrel Therapy in Acute Myocardial Infarction But Not Stable Angina
    Kim, Ho-Sook
    Chang, Kiyuk
    Koh, Yoon-Seok
    Park, Mahn-Won
    Choi, Yun-Seok
    Park, Chul-Soo
    Oh, Minkyung
    Kim, Eun-Young
    Shon, Ji-Hong
    Shin, Jae-Gook
    Seung, Ki-Bae
    CIRCULATION-CARDIOVASCULAR GENETICS, 2013, 6 (05) : 514 - 521
  • [37] The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel
    Tousoulis, Dimitris
    Siasos, Gerasimos
    Zaromitidou, Marina
    Oikonomou, Evangelos
    Maniatis, Konstantinos
    Kioufis, Stamatios
    Kokkou, Eleni
    Papavassiliou, Athanasios G.
    Stefanadis, Christodoulos
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1594 - 1596
  • [38] Gender Differences in Impact of CYP2C19 Polymorphism on Risk of Coronary Artery Disease
    Hokimoto, Seiji
    Akasaka, Tomonori
    Nakagawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2014, 130
  • [39] Gender Differences in Impact of CYP2C19 Polymorphism and Low Grade Inflammation on Coronary Spasm in Patients with Vasospastic Angina (VSA)
    Akasaka, Tomonori
    Hokimoto, Seiji
    Tabata, Noriaki
    Sakamoto, Kenji
    Tsujita, Kenichi
    Kojima, Sunao
    Kaikita, Koichi
    Ogawa, Hisao
    CIRCULATION, 2014, 130
  • [40] STUDY ON THE ASSOCIATION BETWEEN CLOPIDOGREL RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND CYP2C19 POLYMORPHISMS
    Geng, Wang Tian
    Heng, Cao
    HEART, 2011, 97 : A111 - A111
12345